Gene · 3945
Papers2,881
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
801 to 820 of 2,881
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Lactate: The Mediator of Metabolism and Immunosuppression. | Front Endocrinol (Lausanne) | 2022 | 35757394 | PubTator, text mining | PubMed |
| Therapeutic Targeting of Tumor Cells and Tumor Immune Microenvironment Vulnerabilities. | Front Oncol | 2022 | 35756631 | PubTator, text mining | PubMed |
| Early Oxygen Treatment Measurements Can Predict COVID-19 Mortality: A Preliminary Study. | Healthcare (Basel) | 2022 | 35742198 | PubTator, text mining | PubMed |
| A mathematical model of GLUT1 modulation in rods and RPE and its differential impact in cell metabolism. | Sci Rep | 2022 | 35739198 | PubTator, text mining | PubMed |
| The potential of hyperpolarised 13C-MRI to target glycolytic tumour core in prostate cancer. | Eur Radiol | 2022 | 35731287 | PubTator, text mining | PubMed |
| SET domain containing 2 (SETD2) influences metabolism and alternative splicing during myogenesis. | FEBS J | 2022 | 35724320 | PubTator, text mining | PubMed |
| Maternal Immune Dysregulation and Autism-Understanding the Role of Cytokines, Chemokines and Autoantibodies. | Front Psychiatry | 2022 | 35722542 | PubTator, text mining | PubMed |
| Identification of metabolic pathways underlying FGF1 and CHIR99021-mediated cardioprotection. | iScience | 2022 | 35707727 | PubTator, text mining | PubMed |
| Blood-based untargeted metabolomics in relapsing-remitting multiple sclerosis revealed the testable therapeutic target. | Proc Natl Acad Sci U S A | 2022 | 35700359 | PubTator, text mining | PubMed |
| Emerging Role of Epitranscriptomics in Diabetes Mellitus and Its Complications. | Front Endocrinol (Lausanne) | 2022 | 35692393 | PubTator, text mining | PubMed |
| LDHB Overexpression Can Partially Overcome T Cell Inhibition by Lactic Acid. | Int J Mol Sci | 2022 | 35682650 | PubTator, text mining | PubMed |
| LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression. | BMC Cancer | 2022 | 35676659 | PubTator, text mining | PubMed |
| Lactate Dehydrogenase B Is Required for Pancreatic Cancer Cell Immortalization Through Activation of Telomerase Activity. | Front Oncol | 2022 | 35669414 | PubTator, text mining | PubMed |
| Moderate Colitis Not Requiring Intravenous Steroids Is Associated with Improved Survival in Stage IV Melanoma after Anti-CTLA4 Monotherapy, But Not Combination Therapy. | Oncologist | 2022 | 35666292 | PubTator, text mining | PubMed |
| Metabolic reprogramming: a bridge between aging and tumorigenesis. | Mol Oncol | 2022 | 35666002 | PubTator, text mining | PubMed |
| Altered Cellular Immunity and Differentially Expressed Immune-Related Genes in Patients With Systemic Sclerosis-Associated Pulmonary Arterial Hypertension. | Front Immunol | 2022 | 35663995 | PubTator, text mining | PubMed |
| Integrating spatial transcriptomics with single-cell transcriptomics reveals a spatiotemporal gene landscape of the human developing kidney. | Cell Biosci | 2022 | 35659756 | PubTator, text mining | PubMed |
| Tumor-Derived Lactate Creates a Favorable Niche for Tumor via Supplying Energy Source for Tumor and Modulating the Tumor Microenvironment. | Front Cell Dev Biol | 2022 | 35646923 | PubTator, text mining | PubMed |
| Artesunate Inhibits the Development of Esophageal Cancer by Targeting HK1 to Reduce Glycolysis Levels in Areas With Zinc Deficiency. | Front Oncol | 2022 | 35646662 | PubTator, text mining | PubMed |
| Identification of human LDHC4 as a potential target for anticancer drug discovery. | Acta Pharm Sin B | 2022 | 35646544 | Swiss-Prot, curated | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3945/papers?page=41